+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score

Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score

Intensive Care Medicine 39(2): 275-281

The decision to start venovenous extracorporeal membrane oxygenation (VV ECMO) is commonly based on the severity of respiratory failure, with little consideration of the extrapulmonary organ function. The aim of the study was to identify predictors of mortality and to develop a score allowing a better stratification of patients at the time of VV ECMO initiation. This was a prospective multicenter cohort study on 60 patients with influenza A (H1N1)-associated respiratory distress syndrome participating in the Italian ECMOnet data set in the 2009 pandemic. Criteria for ECMO institution were standardized according to national guidelines. The survival rate in patients treated with ECMO was 68 %. Significant predictors of death before ECMO institution by multivariate analysis were hospital length of stay before ECMO institution (OR = 1.52, 95 % CI 1.12-2.07, p = 0.008); bilirubin (OR = 2.32, 95 % CI 1.52-3.52, p < 0.001), creatinine (OR = 7.38, 95 % CI 1.43-38.11, p = 0.02) and hematocrit values (OR = 0.82, 95 % CI 0.72-0.94, p = 0.006); and mean arterial pressure (OR = 0.92, 95 % CI 0.88-0.97, p < 0.001). The ECMOnet score was developed based on these variables, with a score of 4.5 being the most appropriate cutoff for mortality risk prediction. The high accuracy of the ECMOnet score was further confirmed by ROC analysis (c = 0.857, 95 % CI 0.754-0.959, p < 0.001) and by an independent external validation analysis (c = 0.694, 95 % CI 0.562-0.826, p = 0.004). Mortality risk for patients receiving VV ECMO is correlated to the extrapulmonary organ function at the time of ECMO initiation. The ECMOnet score is a tool for the evaluation of the appropriateness and timing of VV ECMO in acute lung failure.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 036761649

Download citation: RISBibTeXText

PMID: 23160769

DOI: 10.1007/s00134-012-2747-1

Related references

A novel risk score for severe ARDS patients undergoing ECMO after retrieval from peripheral hospitals. Acta Anaesthesiologica Scandinavica 62(1): 38-48, 2018

Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score. Critical Care 23(1): 11, 2019

Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. International Journal of Tuberculosis and Lung Disease 15(4): 542-546, 2011

Single-Center Experience With Venovenous ECMO for Influenza-Related ARDS. Journal of Cardiothoracic and Vascular Anesthesia 32(3): 1154-1159, 2018

Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO. Critical Care Research and Practice 2010: 146456, 2010

ECMO criteria for influenza A (H1N1)-associated ARDS: role of transpulmonary pressure. Intensive Care Medicine 38(3): 395-403, 2012

Computed tomography findings from patients with ARDS due to Influenza A (H1N1) virus-associated pneumonia. European Journal of Radiology 81(2): 389-394, 2012

Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable. Plos one 5(9): E12849, 2010

A risk score for predicting 30-day mortality in heart failure patients undergoing non-cardiac surgery. European Journal of Heart Failure 16(12): 1310-1316, 2014

Metabolomic Profile of ARDS by Nuclear Magnetic Resonance Spectroscopy in Patients With H1N1 Influenza Virus Pneumonia. Shock 50(5): 504-510, 2018

Exogenous surfactant as a component of complex non-ECMO therapy of ARDS caused by influenza A virus (2009 H1N1). Bratislavske Lekarske Listy 112(4): 218-222, 2011

A simple risk score for predicting mortality in diabetic patients undergoing percutaneous coronary intervention. Circulation 108(17 Suppl.): IV-717-IV-718, 2003

Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surgery for Obesity and Related Diseases 3(2): 134-140, 2007

Development and validation of a risk score for predicting operative mortality in heart failure patients undergoing surgical ventricular reconstruction. European Journal of Cardio-Thoracic Surgery 47(5): E199-E205, 2015

Mortality and severity evaluation by routine pneumonia prediction models among Japanese patients with 2009 pandemic influenza A (H1N1) pneumonia. Respiratory Investigation 52(5): 280-287, 2014